480 related articles for article (PubMed ID: 17530507)
1. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes.
Vollmer WM; Peters D; Crane B; Kelleher C; Buist AS
COPD; 2007 Jun; 4(2):135-42. PubMed ID: 17530507
[TBL] [Abstract][Full Text] [Related]
2. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
Akazawa M; Biddle AK; Stearns SC
Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
[TBL] [Abstract][Full Text] [Related]
3. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
4. Inhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary disease.
Balkrishnan R; Christensen DB
Clin Ther; 2000 Apr; 22(4):452-69. PubMed ID: 10823366
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
6. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[TBL] [Abstract][Full Text] [Related]
7. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
8. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.
Ernst P; Gonzalez AV; Brassard P; Suissa S
Am J Respir Crit Care Med; 2007 Jul; 176(2):162-6. PubMed ID: 17400730
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies.
Suissa S
Am J Respir Crit Care Med; 2003 Jul; 168(1):49-53. PubMed ID: 12663327
[TBL] [Abstract][Full Text] [Related]
10. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
11. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
12. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
[TBL] [Abstract][Full Text] [Related]
13. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
Fan VS; Bryson CL; Curtis JR; Fihn SD; Bridevaux PO; McDonell MB; Au DH
Am J Respir Crit Care Med; 2003 Dec; 168(12):1488-94. PubMed ID: 14525798
[TBL] [Abstract][Full Text] [Related]
14. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
Kiri VA; Fabbri LM; Davis KJ; Soriano JB
Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832
[TBL] [Abstract][Full Text] [Related]
15. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.
Sin DD; Wu L; Anderson JA; Anthonisen NR; Buist AS; Burge PS; Calverley PM; Connett JE; Lindmark B; Pauwels RA; Postma DS; Soriano JB; Szafranski W; Vestbo J
Thorax; 2005 Dec; 60(12):992-7. PubMed ID: 16227327
[TBL] [Abstract][Full Text] [Related]
16. Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary disease.
Calverley PM
Proc Am Thorac Soc; 2004; 1(3):161-6. PubMed ID: 16113429
[TBL] [Abstract][Full Text] [Related]
17. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
Singh S; Amin AV; Loke YK
Arch Intern Med; 2009 Feb; 169(3):219-29. PubMed ID: 19204211
[TBL] [Abstract][Full Text] [Related]
18. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
Gershon AS; Wang L; To T; Luo J; Upshur RE
COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
[TBL] [Abstract][Full Text] [Related]
19. Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology.
Seemungal T; Stockley R; Calverley P; Hagan G; Wedzicha JA
COPD; 2007 Sep; 4(3):177-83. PubMed ID: 17729060
[TBL] [Abstract][Full Text] [Related]
20. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.
Dormuth CR; Glynn RJ; Neumann P; Maclure M; Brookhart AM; Schneeweiss S
Clin Ther; 2006 Jun; 28(6):964-78; discussion 962-3. PubMed ID: 16860179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
